Moreno-Vargas Angelina Daniela, Andrade-Cetto Adolfo, Espinoza-Hernández Fernanda Artemisa, Mata-Torres Gerardo
Laboratorio de Etnofarmacología, Facultad de Ciencias, Universidad Nacional Autónoma de México, Ciudad Universitaria, Coyoacán, Mexico.
Posgrado en Ciencias Biológicas, Unidad de Posgrado, Ciudad Universitaria, Coyoacán, Mexico.
Front Pharmacol. 2024 Oct 16;15:1436927. doi: 10.3389/fphar.2024.1436927. eCollection 2024.
Lotsy (Euphorbiaceae) is an important traditional medicine that is used by the Cakchiquels of Guatemala to control hyperglycemia in patients with type 2 diabetes. Previous studies have shown that administration of this plant induces an acute hypoglycemic effect during fasting and that the main compound is junceic acid, a diterpenoid with a clerodane skeleton; however, junceic acid has not been reported to have hypoglycemic activity in the literature. As the mechanisms involved in the hypoglycemic effect of remain unknown, the objective of the present investigation was to elucidate the hypoglycemic mechanisms of this species, as well as its major compound, junceic acid. The results indicated that, similar to complete extract, junceic acid exhibited a hypoglycemic effect in hyperglycemic rats. Both extract and junceic acid inhibited the activity of two rate-limiting enzymes involved in hepatic glucose production; however, compared with chlorogenic acid, junceic acid had a more potent effect on glucose-6-phosphatase levels than chlorogenic acid, which was used as a positive control. Furthermore, both fasting and postprandial insulin levels decreased in healthy and hyperglycemic rats despite reduced blood glucose levels in both metabolic states, suggesting a potential insulin-sensitizing effect. However, neither of these compounds potentiated the effect of insulin in insulin tolerance tests nor inhibited the enzyme activity of protein tyrosine phosphatase 1B, a negative regulator of the insulin pathway. Therefore, the insulin-sensitizing effect is thought to be independent of insulin and mediated by potential activation of the AMP-activated protein kinase pathway. The specific activation of this master regulator in β-cells results in the inhibition of insulin secretion in a healthy state and the restoration of the insulin response under conditions of glucotoxicity; these effects were observed after the administration of the extract and junceic acid in healthy and hyperglycemic rats. Overall, the main findings of this study establish a basis of the mechanisms of action of and its main compound, junceic acid, in terms of their hypoglycemic effect.
大戟科的洛西属植物是一种重要的传统药物,危地马拉的卡克奇克尔人用它来控制2型糖尿病患者的高血糖。先前的研究表明,服用这种植物会在禁食期间产生急性降血糖作用,其主要化合物是松香酸,一种具有克罗烷骨架的二萜类化合物;然而,文献中尚未报道松香酸具有降血糖活性。由于该植物降血糖作用的机制尚不清楚,本研究的目的是阐明该物种及其主要化合物松香酸的降血糖机制。结果表明,与完整提取物相似,松香酸在高血糖大鼠中表现出降血糖作用。该植物提取物和松香酸均抑制了参与肝脏葡萄糖生成的两种限速酶的活性;然而,与用作阳性对照的绿原酸相比,松香酸对葡萄糖-6-磷酸酶水平的影响更强。此外,健康和高血糖大鼠的空腹和餐后胰岛素水平均下降,尽管两种代谢状态下血糖水平均降低,这表明其具有潜在的胰岛素增敏作用。然而,在胰岛素耐受性试验中,这些化合物均未增强胰岛素的作用,也未抑制胰岛素信号通路的负调节因子蛋白酪氨酸磷酸酶1B的酶活性。因此,胰岛素增敏作用被认为与胰岛素无关,而是由AMP激活的蛋白激酶途径的潜在激活介导的。这种主要调节因子在β细胞中的特异性激活在健康状态下会抑制胰岛素分泌,在糖毒性条件下会恢复胰岛素反应;在健康和高血糖大鼠中给予该植物提取物和松香酸后观察到了这些作用。总体而言,本研究的主要发现为该植物及其主要化合物松香酸的降血糖作用机制奠定了基础。